Zobrazeno 1 - 10
of 114
pro vyhledávání: '"E. A. Mershina"'
Publikováno v:
Вестник рентгенологии и радиологии, Vol 104, Iss 6, Pp 348-362 (2024)
Metformin is a sugar-lowering drug that is actively used in long-term therapy of type 2 diabetes mellitus (DM2). The safety of metformin for different groups of DM2 patients is currently well studied. However, the drug is contraindicated for patients
Externí odkaz:
https://doaj.org/article/9d421b93a23241e0be6556697631314b
Autor:
Y. V. Stavtseva, E. A. Mershina, T. V. Lobzhanidze, E. I. Bazdireva, N. I. Khutsishvili, Zh. D. Kobalava
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 1, Pp 57-62 (2024)
The article describes a clinical case of biventricular arrhythmogenic cardiomyopathy (ACM) presented with myocardial infarction (MI) — like event in a young patient. The patient was hospitalized with suspected acute coronary syndrome and an episode
Externí odkaz:
https://doaj.org/article/16937dc54cce493a9f159d33f2a6743c
Autor:
E. A. Mershina, D. A. Filatova, M. V. Lisitskaya, E. V. Ryzhkova, R. P. Myasnikov, V. E. Sinitsyn
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 6, Pp 565-571 (2023)
An increase in left ventricular (LV) extracellular volume (ECV) is an important parameter of LV morphology and is considered synonymous with myocardial fibrosis, as well as a reliable marker of myocardial injury and impaired cardiac function. Accurat
Externí odkaz:
https://doaj.org/article/8174408090484e24aeb0fc5ee4317c7d
Autor:
E. K. Erokhina, K. V. Shamtieva, E. A. Melnik, D. O. Kazakov, S. A. Kurbatov, E. P. Pavlikova, O. A. Tikhonova, E. A. Mershina, V. E. Sinitsyn, D. V. Vlodavets
Publikováno v:
Нервно-мышечные болезни, Vol 14, Iss 2 (2024)
Background. Myotonic dystrophy type 1 (DM1) is a hereditary slowly progressive multisystem disease with an autosomal dominant mode of inheritance, caused by the expansion of trinucleotide (CTG)n repeats in the 3’ untranslated region of the DMPK gen
Externí odkaz:
https://doaj.org/article/002ad306ab4241e18b1f04d4f7cc328f
Autor:
E. A. Mershina, D. A. Filatova, R. P. Myasnikov, O. V. Kulikova, A. N. Meshkov, A. V. Kiseleva, V. E. Sinitsyn, M. S. Kharlap
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 3 (2024)
Aim. To analyze contrast-enhanced cardiac magnetic resonance imaging (MRI) in patients with phenotypic manifestations of left ventricular non-compaction (LVNC) and related genetic mutations, as well as to determine the relationship between mutations
Externí odkaz:
https://doaj.org/article/bb7484119c08431da236aa0f35cfd4d8
Autor:
M. M. Kudryavtseva, E. V. Ryzhkova, O. V. Kulikova, E. A. Mershina, V. E. Sinitsyn, O. M. Drapkina, R. P. Myasnikov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 2 (2024)
Left ventricular (LV) hypertrophy implies structural cardiac changes and, as a consequence, an increase in myocardial mass. Currently, there are many causes of this condition as follows: hypertension, aortic stenosis, hypertrophic cardiomyopathy, exe
Externí odkaz:
https://doaj.org/article/8ca17cb5493a455c880ac2ca96393d49
Autor:
G. A. Burnasheva, R. P. Myasnikov, O. V. Kulikova, M. M. Kudryavtseva, E. A. Mershina, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 12 (2023)
Hypertrophic cardiomyopathy (HCM) at the cellular level is characterized by hypertrophy, cardiomyocyte disorganization and myocardial fibrosis areas. The leading death cause in HCM remains sudden cardiac death (SCD). Despite the existing risk scores
Externí odkaz:
https://doaj.org/article/b35a02bc6fba465f9fbc6224cca9874e
Autor:
R. P. Myasnikov, N. N. Kuzina, D. A. Nefedova, A. V. Kiseleva, O. V. Kulikova, A. N. Meshkov, M. M. Kudryavtseva, E. A. Mershina, M. g. Divashuk, E. V. Ryzhkova, M. S. Kharlap, O. M. Drapkina
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 11 (2023)
Inherited cardiomyopathies (CMP) are a group of heterogeneous diseases characterized by myocardial disorders that is not caused by coronary artery disease, hypertension, valvular and congenital defects. With the development of imaging methods and mol
Externí odkaz:
https://doaj.org/article/edf30b19433b45eba60ff5615a6f1553
Autor:
O. V. Blagova, E. V. Pavlenko, N. V. Varionchik, V. P. Sedov, N. V. Gagarina, E. A. Mershina, M. E. Polyak, E. V. Zaklyazminskaya, A. V. Nedostup
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 1, Pp 27-35 (2022)
Aim. To study the place of NCM in the structure of DCM, its clinical features and influence on prognosis in comparison with other forms of DCM syndrome.Methods. The NCM registry includes 125 patients, mean age 46.4±15.1 years, 74 men and 51 women, m
Externí odkaz:
https://doaj.org/article/fa8149e033874d1eb376784f7edbbc68
Autor:
M. M. Kudryavtseva, A. V. Kiseleva, R. P. Myasnikov, O. V. Kulikova, A. N. Meshkov, E. A. Mershina, R. K. Angarsky, Е. A. Sotnikova, M. G. Divashuk, A. A. Zharikova, S. N. Koretsky, D. A. Filatova, V. E. Sinitsyn, N. A. Sdvigova, V. I. Barsky, E. N. Basargina, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 12 (2023)
Left ventricular non-compaction (LVNC) is a rare, genetically and phenotypically heterogeneous disease, which is often accompanied by diagnostic difficulties.Aim. To demonstrate several generations of a family with LVNC with various clinical and phen
Externí odkaz:
https://doaj.org/article/67bab5e29c354e2bbd78fca1a22a2182